Dear Members,

We are excited to release the Learning Community Series Report, Recommended Best and Promising Practices on Adult Vaping Cessation Services for Quitlines. The main purpose of this report is to provide recommendations to the quitline community on best or promising practices for adult vaping cessation in the areas of pharmacotherapy and counselling (listed below). This report focuses on vaping cessation for adults only, not youth, as cessation pharmacotherapy (nicotine replacement therapy, bupropion SR, and varenicline) is approved by the Food and Drug Administration (FDA) for adults ages 18 years and over can be offered by quitlines to their participants who seek to quit use of e-cigarettes. A separate Learning Community report in 2022 will focus on youth cessation and incorporate aspects of e-cigarette use that are specific to youth ages 17 years and under.

NAQC's Advisory Council reviewed the recommendations and the quitline community was also invited to provide feedback. Please contact Katie Mason at Kmason@naquitline.org if you have any associated questions.

Pharmacotherapy Recommendation: All quitlines should use a validated method to assess the level of nicotine use or dependence and to guide dosing of cessation pharmacotherapy for adult quitline participants.
Implementation by June 30, 2023

Counseling Recommendation: All quitlines should offer counseling that establishes the adult quitline participant’s use of e-cigarettes and tailors counseling accordingly.
Implementation by June 30, 2023

NAQC will track adoption of the recommendations in this report throughout the coming years. Our dialogue with the Quitline community will continue to better understand barriers to adoption and to share strategies for successful adoption and implementation. NAQC is available to answer questions, provide technical assistance, and facilitate dialogue among the Quitline community. 

We look forward to working in collaboration with the Quitline community to better reach and serve people who use tobacco, including e-cigarettes and to make progress on these recommendations.

Sincerely,